Interv Akut Kardiol. 2006;5(3):103
Interv Akut Kardiol. 2006;5(3):112-115
In patients with heart failure, natriuretic peptide level and its change during the course of treatment may be a prognostic marker of their long-term survival. Our aim was to assess the relation between natriuretic peptide level and the two-year survival in patients with heart failure and chronic renal failure in a long-term dialysis programme. Initial tests which included BNP (pg/ml), NT-proBNP (pg/ml), and echocardiography were performed in 30 long-term dialysis programme patients with confirmed left ventricular hypertrophy but without unequivocal clinical signs of heart failure. After two years, our cohort was divided into patients who were still...
Interv Akut Kardiol. 2006;5(3):116-121
The article presents a brief overview of the management of patients after heart transplantation and the solving of possible problems which can be encountered in this special clinical situation. It may serve as a basic information source for cardiologists who are not routinely faced with these issues. To obtain more detailed information references are listed, mainly from the home literature.
Interv Akut Kardiol. 2006;5(3):122-130
Within the last decades, radiofrequency ablations of supraventricular arrhythmias have advanced considerably from being an experimental method to becoming the first choice method in the treatment of many supraventricular tachycardias. In the present article, we describe the pathophysiological mechanisms, ECG patterns, techniques and results of radiofrequency ablations of the most common supraventricular arrhythmias – atrioventricular nodal reentrant tachycardia, accessory pathways, typical and atypical atrial flutter, focal atrial tachycardias and atrial fibrillation.
Interv Akut Kardiol. 2006;5(3):131-134
The first clinically used percutaneous ventricular assisting device (pVAD Tandem Heart™ developed by CardiacAssist Inc, Pittsburgh, PA, USA) is designed to stabilize circulation in cardiogenic shock patients who are candidates for definitive therapy with catheterization or surgery. The device is based on the principle of left atrial-to-femoral arterial bypass using a low-speed continuous-flow centrifugal pump. It can be inserted solely by percutaneous technique without the need for surgical intervention in an intervention cardiology setting. This system has been employed at our centre since January 2005. We report cases of cardiogenic shock...
Interv Akut Kardiol. 2006;5(3):135-138
Spontanous coronary artery dissection is rare cause of acute coronary syndrome involving mostly young women, obviously during the peripartum or in association with oral contraceptive use. SCAD mostly inolves left anterior descending artery. Treatment should be conservative or PCI using koronary stent or surgical by using bypass. The authors support the case of repeated spontneoust coronary artery dissection.
Interv Akut Kardiol. 2006;5(3):110
Interv Akut Kardiol. 2006;5(3):111
Interv Akut Kardiol. 2006;5(3):141-142
Interv Akut Kardiol. 2006;5(3):139-140
Indirect factor Xa inhibitor fondaparinux proved beneficial effect for STEMI treatment only in patients without primary angioplasty. Clinical benefit of primary angioplasty is clearly superior to other treatment modalities of myocardial infarction.